NeuralTeks
PrivateLast Round
Seed
Jan 29, 2025
Est. Valuation
$3M
Total Funding Raised
$240,000
Company Overview
NeuralTeks is a healthtech company that develops an AI-driven multimodal platform for laboratory image analysis to enhance microbiological studies.
Sector
Enterprise Software
Verticals
Workflow Automation, E-commerce
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuralTeks Comparables
Compare NeuralTeks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImageProVision Technology Pvt. Ltd. | 45% | |
NeuralTeks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 29, 2025 | ||||
| Accelerator | Nov 6, 2024 | ||||
| Accelerator | Sep 9, 2024 |
Key People
Founding team and executive leadership
NeuralTeks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paris Biotech Santé | Seed |
| Techstars | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
Monthly visitors grew 343% MoM, from 54 to 239.
NeuralTeks Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuralTeks's valuation, stock price, and market status.